Safety and Efficacy of Multimodal Thermal Therapy (MTT) Combined With KRAS G12V mRNA Vaccine, S-1, and Sintilimab in Patients With Metastatic Pancreatic Cancer

NCT07745790 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Ductal Adenocarcinoma
Liver Neoplasms
Lung Neoplasms

Interventions

DEVICE: Multimodal Thermal Therapy (MTT) System
BIOLOGICAL: KRAS G12V mRNA Vaccine
DRUG: Sintilimab
DRUG: S-1

Sponsor

Ruijin Hospital